Tilbroquinol Uses, Dosage, Side Effects and more
Tilbroquinol was approved in France, Morocco, and Saudi Arabia but it has been withdrawn in France and Saudi Arabia markets mainly due to its hepatotoxicity risk outweighing the drug benefit . In Morocco, the drug has been limited to use in the treatment of intestinal amoebiasis.
| Trade Name | Tilbroquinol |
| Generic | Tilbroquinol |
| Tilbroquinol Other Names | Tilbroquinol |
| Type | |
| Formula | C10H8BrNO |
| Weight | Average: 238.084 Monoisotopic: 236.978927 |
| Groups | Approved |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
